Search Results
Nov 30, 2025, 09:34 ET TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will
More news about: Faruqi & Faruqi, LLP
Nov 28, 2025, 17:25 ET Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
PET imaging agent. The CRL, a formal rejection of the application, identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package."Crucially, the FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply
More news about: Hagens Berman Sobol Shapiro LLP
Nov 28, 2025, 08:00 ET BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough
nasopharyngeal carcinomaThe company enables seamless Europe–China tech transfer and faster biologics development through an integrated, end-to-end CMC platformSUZHOU, China, Nov. 28, 2025 /PRNewswire/ --
More news about: BioDlink Biopharm Co., Ltd.
Nov 26, 2025, 16:15 ET Commercial Metals Company Announces Closing of $2,000 Million Senior Notes Offering
IRVING, Texas, Nov. 26, 2025 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") announced today that it has closed its previously announced offering of $1,000 million in aggregate principal amount
More news about: Commercial Metals Company
Nov 26, 2025, 08:50 ET Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
PET imaging agent. The CRL, a formal rejection of the application, identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package."Crucially, the FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply
More news about: Hagens Berman Sobol Shapiro LLP
Nov 25, 2025, 20:03 ET Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
PET imaging agent. The CRL, a formal rejection of the application, identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package."Crucially, the FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain
More news about: Hagens Berman Sobol Shapiro LLP
Nov 24, 2025, 10:17 ET Leica Biosystems and L7 Informatics Announce Strategic Partnership to Develop the Next Generation of Informatics Solutions to Improve Operational Efficiency in Pathology Labs
sciences with L7|ESP®, the Enterprise Science Platform built to unify data, orchestrate and automate workflows, and enable AI operations across R&D, CMC, manufacturing, QC, diagnostics, and clinical environments. L7|ESP connects the dots between disparate instruments, software, and teams by providing
More news about: L7 Informatics
Nov 21, 2025, 17:32 ET Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up
Mello, who engaged in in-depth discussions on cutting-edge CGT topics, including the transition from ex vivo to in vivo therapies, strategies to overcome CMC challenges in manufacturing, and capital and collaboration trends.Global Leaders Converge on the Next Era of CGTThe forum was moderated
More news about: GenScript Biotech Corporation
Nov 21, 2025, 10:19 ET UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will
More news about: Faruqi & Faruqi, LLP
Nov 21, 2025, 08:00 ET BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC
multimedia:https://www.prnewswire.com/news-releases/biodlink-and-lepu-biopharma-celebrate-successful-launch-of-the-worlds-first-egfr-targeting-adc-drug-marking-a-major-milestone-in-mutual-collaboration-in-biologics-cmc-302623064.htmlSOURCE
More news about: BioDlink Biopharm Co., Ltd.
Nov 21, 2025, 03:01 ET HRV Pharma and MetroChem Forge Strategic CDMO Alliance to Fast-Track High-Value NCE-1 API Development
of five initial programs, with additional molecules planned for development under a unified framework.Both organizations will jointly manage CMC documentation, stability studies, validation programs, and global regulatory interactions, creating a seamless development-to-commercialization pathway.This
More news about: HRV Pharma
Nov 19, 2025, 10:15 ET Common-mode Chokes Market worth $0.92 billion by 2030 - Exclusive Report by MarketsandMarkets™
high-speed data interfaces (Wi-Fi, Bluetooth, USB, HDMI, SerDes), and RF modules that generate and are sensitive to common-mode noise, driving widespread CMC use across multiple nodes in each device. Additionally, stringent EMI/EMC regulations and the need for enhanced efficiency and communication reliability
More news about: MarketsandMarkets
Nov 19, 2025, 09:13 ET Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
press release due to the risks and uncertainties inherent in Avidity's business and beyond its control, including, without limitation: the additional CMC data to be submitted by Avidity as requested by the FDA, among other data and information to be included in a BLA for del-zota, may not be satisfactory
More news about: Avidity Biosciences, Inc.
Nov 18, 2025, 08:00 ET Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC (Chemistry Manufacturing and Controls) information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase
More news about: Acurx Pharmaceuticals, Inc.
Nov 17, 2025, 07:00 ET CoinMarketCap and Reserve Unveil CMC20, the First DeFi-Native Tradable Crypto Index Token on BNB Chain
transparent collateralization and redemption mechanics. Users can mint CMC20 by depositing the underlying basket of tokens or redeem CMC20 for its constituent assets at any time, maintaining tight tracking to index value. "CMC20 showcases what is unlocked by crypto and Defi infrastructure,"
More news about: Reserve
Nov 17, 2025, 07:00 ET CoinMarketCap and Reserve Unveil CMC20, the First DeFi-Native Tradable Crypto Index Token on BNB Chain
collateralization and redemption mechanics. Users can mint CMC20 by depositing the underlying basket of tokens or redeem CMC20 for its constituent assets at any time, maintaining tight tracking to index value. "CMC20 showcases what is unlocked by crypto and Defi infrastructure,"
More news about: Reserve
Nov 14, 2025, 10:29 ET TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will
More news about: Faruqi & Faruqi, LLP
Nov 14, 2025, 10:23 ET LAST CALL: Join Nobel Laureate & Global Leaders to Explore the Next Era of Cell & Gene Therapy in London
3rd panel: From Lab to Patient: Overcoming CMC Barriers in Cell and Gene Therapy Manufacturing Despite its promise, CGT faces manufacturing challenges, with CMC hurdles impacting reproducibility, scalability, and regulatory compliance.
More news about: GenScript Biotech Corporation
Nov 13, 2025, 08:05 ET Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids
In parallel with this regulatory clarity, the Company is on track to initiate a comprehensive Chemistry, Manufacturing, and Controls (CMC) plan. The initiation of this plan represents a key operational milestone, focusing on scaling production and ensuring the quality and consistency of
More news about: Tharimmune, Inc.
Nov 12, 2025, 20:20 ET Survey Reveals Majority of New England Families Seek Senior Care Only in a Crisis
"We often hear from seniors and families that they only seek help and advice once they are in a health crisis," said Jennifer Pilz, MS, PT, CMC, President of ALCA NE Chapter, "Proactive planning, research, and guidance are not a priority, which can often lead to a more difficult — and much more
More news about: Aging Life Care Association
Nov 12, 2025, 18:00 ET Commercial Metals Company Prices Offering of $2,000 Million Senior Notes in Two Tranches
IRVING, Texas, Nov. 12, 2025 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") announced today that it has agreed to sell $1,000 million in aggregate principal amount of 5.75% Senior Notes due 2033
More news about: Commercial Metals Company
Nov 12, 2025, 15:15 ET OAGi and NIIMBL Announce Release of Biopharmaceutical Manufacturing Ontologies to Advance Interoperability and Analytics
that dramatically improve usability for ontology specialists and implementation teams," stated Elyse Easson, Director, Commercialization and Digital CMC Value Team, Digital MMD. The biopharmaceutical manufacturing sector has expressed strong support for the availability of this
More news about: National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Nov 12, 2025, 07:58 ET Commercial Metals Company Announces Proposed Private Offering of $2,000 Million Senior Notes
IRVING, Texas, Nov. 12, 2025 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") announced today that it intends to offer to sell, subject to market and other conditions, $2,000 million in aggregate
More news about: Commercial Metals Company
Nov 12, 2025, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC (Chemistry Manufacturing and Controls) information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase
More news about: Acurx Pharmaceuticals, Inc.
Nov 10, 2025, 19:54 ET TLX INVESTOR ALERT: Telix Pharmaceuticals Ltd. Investors with Substantial Losses Have Opportunity to Lead the Telix Class Action Lawsuit - RGRD Law
the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will
More news about: Robbins Geller Rudman & Dowd LLP